Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Travel With Dihexa Airplane TSA: Peptide Comparison

Dihexa −20°C (tolerates 25°C for 24–48h) 2–8°C (refrigeration required) Powder exempt; liquid requires declaration 36–48h with peptide cooler Moderate tolerance in powder form; fragile once reconstituted. Declare at checkpoint with lab documentation. Cerebroly

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Dihexa
  • −20°C (tolerates 25°C for 24–48h)
  • 2–8°C (refrigeration required)
  • Powder exempt; liquid requires declaration
  • 36–48h with peptide cooler
  • Moderate tolerance in powder form; fragile once reconstituted. Declare at checkpoint with lab documentation.
  • Cerebrolysin
  • 2–8°C (pre-filled ampules)
  • N/A (single-use format)
  • Liquid format requires declaration
  • 24–36h with insulated cooler
  • Pre-filled format simplifies transport but must remain refrigerated. Higher scrutiny due to injectable presentation.
  • P21
  • −20°C (lyophilised powder)
  • Similar profile to Dihexa. Stable in powder form but requires cold chain once reconstituted.
  • Thymalin
  • Standard lyophilised peptide protocol applies. Declaration reduces checkpoint friction.
  • This table shows how Dihexa's storage and transport requirements align with other research peptides commonly transported through TSA checkpoints. The critical variable is reconstitution status. Powder form significantly simplifies compliance.